AML glossary · UK

Proliferation financing

Definition

Proliferation financing is the provision of funds or financial services to support the development, production, or acquisition of weapons of mass destruction — including nuclear, chemical, biological, and radiological weapons. Following the 2022 update to MLR 2017, regulated businesses including accountants are required to include proliferation financing risk in their firm-wide risk assessments.

In practice

most accountancy clients present no proliferation financing risk. However, firms with clients involved in defence, dual-use goods, or international trade with sanctioned states should include a specific proliferation assessment in their risk documentation.

Before you treat Proliferation financing as handled

  • Confirm which regulation, policy, or internal procedure the term maps to.
  • Document the decision or evidence trail in the client file, not only in email or chat.
  • Escalate where the term indicates higher risk, sanctions exposure, PEP status, suspicion, or missing evidence.
  • Keep the wording consistent across onboarding, review notes, training material, and inspection packs.

Put Proliferation financing into practice with Certivus

Knowing the term is the first step. Certivus gives you the workflows — client intake, CDD, EDD, PEP and sanctions screening, audit-ready records — to apply it across every client.

Back to the full glossary